Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Oxidative Medicine and Cellular Longevity|September 13, 2021
XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 PathwayPeng Lv, Haoran Liu, Tao Ye, et al.
Frontiers in Surgery|January 19, 2026
The clinical efficacy of novel semirigid ureteroscopy with a vacuum suction device for treatment of >10 mm upper ureteral stones and impacted calculus: implications for clinical practiceLonghui Lai, Yuanfeng Zhang, Yingru Wang, et al.
Molecular Therapy. Nucleic Acids|March 26, 2021
CD46 splice variant enhances translation of specific mRNAs linked to an aggressive tumor cell phenotype in bladder cancerJin Zeng, Hua Xu, Chunhua Huang, et al.
Scientific Reports|July 20, 2024
PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancerYu Fan, Tao Dai, Dahong Zhang, et al.
Med (New York, N.Y.)|October 17, 2024
Correlation of PSA and survival in metastatic hormone-sensitive prostate cancer treated with rezvilutamide plus ADT in the CHART trialXiaojie Bian, Weijie Gu, Xuepei Zhang, et al.
European Urology|November 16, 2017
Efficacy and Safety of Tamsulosin in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Multicenter, Randomized, Double-blind, Placebo-controlled TrialZhangqun Ye, Guohua Zeng, Huan Yang, et al.
BJU International|April 9, 2019
The status and characteristics of urinary stone composition in ChinaZhangqun Ye, Guohua Zeng, Huan Yang, et al.
Chinese Medical Journal|April 3, 2023
Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trialChengyuan Gu, Zengjun Wang, Tianxin Lin, et al.
World Journal of Urology|October 30, 2017
Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortiumTianxin Lin, Kaiwen Li, Hao Liu, et al.
Asian Journal of Urology|December 22, 2017
Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium databaseKaiwen Li, Tianxin Lin, , et al.
Pageof 8